New Data and Clinical Factors Contributing to CDK4/6 Inhibitor Selection

Video

Two breast cancer experts delve into key data from various CDK4/6 inhibitor studies, focusing on safety, efficacy, and how these agents might be implemented in the clinic.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos